Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Xilio Therapeutics Inc.

    NASDAQ: XLO · Real-Time Price · USD
    0.71
    0.00 (0.14%)
    At close: Aug 18, 2025, 3:59 PM

    Xilio Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 6.34M n/a n/a n/a
    Cost of Revenue
    		 n/a 1.9M 1.85M 1.5M
    Gross Profit
    		 6.34M -1.9M -1.85M -1.5M
    Operating Income
    		 -60.58M -79.13M -89.15M -75.04M
    Interest Income
    		 n/a n/a n/a 600.00
    Pretax Income
    		 -58.24M -76.4M -88.22M -75.8M
    Net Income
    		 -58.24M -76.4M -87.3M -74.3M
    Selling & General & Admin
    		 24.78M 27M 29.95M 23.86M
    Research & Development
    		 41.21M 52.14M 59.2M 51.19M
    Other Expenses
    		 937K n/a 927K -756K
    Operating Expenses
    		 66.93M 79.13M 89.15M 75.04M
    Interest Expense
    		 n/a n/a n/a 600K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 66.93M 79.13M 89.15M 75.04M
    Income Tax Expense
    		 n/a n/a -927K -1.5M
    Shares Outstanding (Basic)
    		 53.51M 27.5M 27.39M 27.36M
    Shares Outstanding (Diluted)
    		 53.51M 27.5M 27.39M 27.36M
    EPS (Basic)
    		 -1.09 -2.78 -3.19 -2.72
    EPS (Diluted)
    		 -1.09 -2.78 -3.19 -2.72
    EBITDA
    		 -58M -73.8M -85.58M -73.7M
    EBIT
    		 -59.65M -75.7M -87.42M -75.2M
    Depreciation & Amortization
    		 1.64M 1.9M 1.85M 1.5M

    Add to Watchlist